Texas
HB2972
HB2972 - Relating to the medical use of low-THC cannabis by patients with certain medical conditions.
Source: Congress.gov ·
239 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
  89R12079 RDR-D     By: Plesa H.B. No. 2972       A BILL TO BE ENTITLED   AN ACT   relating to the medical use of low-THC cannabis by patients with   certain medical conditions.          BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:          SECTION 1.  Section 169.003, Occupations Code, is amended to   read as follows:          Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS. A   physician described by Section 169.002 may prescribe low-THC   cannabis to a patient if:                (1)  the patient is a permanent resident of the state;                (2)  the physician complies with the registration   requirements of Section 169.004; and                (3)  the physician certifies to the department that:                      (A)  the patient is diagnosed with:                            (i)  epilepsy;                            (ii)  a seizure disorder;                            (iii)  multiple sclerosis;                            (iv)  spasticity;                            (v)  amyotrophic lateral sclerosis;                            (vi)  autism;                            (vii)  cancer;                            (viii)  an incurable neurodegenerative   disease;                            (ix)  post-traumatic stress disorder; [ or ]                            (x)   a condition that causes menstrual   cramps, including premenstrual dysphoric disorder or dysmenorrhea;   or                             (xi) a medical condition that is approved for   a research program under Subchapter F, Chapter 487, Health and   Safety Code, and for which the patient is receiving treatment under   that program; and                      (B)  the physician determines the risk of the   medical use of low-THC cannabis by the patient is reasonable in   light of the potential benefit for the patient.          SECTION 2.  This Act takes effect September 1, 2025.
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.